CN Stock MarketDetailed Quotes

002932 Wuhan Easy Diagnosis Biomedicine

Watchlist
  • 18.64
  • +0.12+0.65%
Market Closed 02/22 15:00 CST
4.33BMarket Cap8.41P/E (TTM)

Wuhan Easy Diagnosis Biomedicine Key Stats

All
YOY yoy
Hide blank lines yoy
(Q9)2023/09/30
(Q6)2023/06/30
(Q3)2023/03/31
(FY)2022/12/31
(Q9)2022/09/30
(Q6)2022/06/30
(Q3)2022/03/31
(FY)2021/12/31
(Q9)2021/09/30
(Q6)2021/06/30
Total operating revenue
-91.62%625.93M
-89.77%537.56M
-85.03%372.4M
272.12%10.53B
285.38%7.47B
360.27%5.25B
267.41%2.49B
195.05%2.83B
202.78%1.94B
216.55%1.14B
Operating revenue
-91.62%625.93M
-89.77%537.56M
-85.03%372.4M
272.12%10.53B
285.38%7.47B
360.27%5.25B
267.41%2.49B
195.05%2.83B
202.78%1.94B
216.55%1.14B
Other operating revenue
----
--0
----
--0
----
--0
----
--0
----
--0
Total operating cost
-79.34%561.15M
-75.47%453.35M
-59.61%305.5M
301.42%4.5B
285.64%2.72B
329.94%1.85B
223.85%756.38M
176.17%1.12B
217.81%704.16M
274.25%429.77M
Operating cost
-85.91%323.72M
-82.69%279.97M
-67.92%208.22M
393.78%3.49B
395.32%2.3B
499.38%1.62B
310.85%649.07M
238.30%707.03M
290.56%463.93M
360.40%269.81M
Operating tax surcharges
-93.71%2.64M
-92.69%2.29M
-84.88%1.8M
366.92%59.79M
360.30%41.98M
451.13%31.36M
261.13%11.87M
131.69%12.8M
192.50%9.12M
215.06%5.69M
Operating expense
-38.92%115.48M
-34.73%82.1M
-7.09%45.96M
128.05%450.77M
64.88%189.05M
62.31%125.78M
32.42%49.47M
114.06%197.66M
126.29%114.67M
185.48%77.49M
Administration expense
26.87%78.33M
37.23%52.31M
47.18%28.13M
86.95%141.98M
42.22%61.74M
29.79%38.12M
36.85%19.11M
141.35%75.95M
183.08%43.41M
216.17%29.37M
Financial expense
-115.39%-65.66M
-63.32%-35.26M
-505.52%-11.79M
-494.15%-34.94M
-435.73%-30.48M
-1,082.02%-21.59M
-29.28%-1.95M
-125.24%-5.88M
-327.74%-5.69M
-33.64%-1.83M
-Interest expense (Financial expense)
-38.55%1.18M
84.58%2.46M
----
61.85%3.42M
20.70%1.91M
-8.64%1.33M
-38.17%477.77K
223.16%2.11M
6.69%1.59M
123.20%1.46M
-Interest Income (Financial expense)
-508.99%-71.2M
-351.55%-36.36M
----
-51.70%-17.73M
-44.07%-11.69M
-48.34%-8.05M
-66.26%-3.79M
-139.87%-11.69M
-139.44%-8.12M
-198.30%-5.43M
Research and development
-31.34%106.63M
26.41%71.93M
15.22%33.18M
192.56%388.36M
97.29%155.31M
15.58%56.91M
28.16%28.8M
89.82%132.74M
125.01%78.72M
154.33%49.23M
Credit Impairment Loss
199.34%71.82M
173.43%43.87M
107.08%2.72M
-1,635.03%-370.09M
-307.06%-72.3M
-476.05%-59.74M
-699.11%-38.48M
-228.15%-21.33M
-204.74%-17.76M
-195.55%-10.37M
Asset Impairment Loss
--36.33M
----
----
---646.67M
----
----
----
--0
----
----
Other net revenue
413.32%154.57M
288.91%86.45M
190.69%30.88M
-8,039.46%-953.31M
-222.06%-49.33M
-368.99%-45.76M
-28.98%-34.04M
-232.64%-11.71M
-244.03%-15.32M
-350.23%-9.76M
Fair value change income
----
----
----
--2.76M
----
----
----
--0
----
----
Invest income
87.02%29.67M
292.16%29.28M
402.51%22.23M
5,116.17%35.12M
869.73%15.86M
7,148.59%7.47M
1,902.43%4.42M
-48.61%673.29K
-37.91%1.64M
142.62%102.99K
Net open hedge income
----
----
----
--0
----
----
----
--0
----
----
-Including: Investment income associates
---2.36M
-637.28%-2.36M
----
11.17%-5.13M
----
89.14%-320.55K
----
11.10%-5.78M
16.39%-2.95M
16.39%-2.95M
Exchange income
----
----
----
--0
----
----
----
--0
----
----
Asset deal income
---413.2K
---269.11K
----
--9.73K
----
----
----
--0
----
----
Other revenue
141.64%17.16M
108.53%13.57M
38,569.24%5.92M
185.75%25.56M
779.25%7.1M
1,177.73%6.51M
106.51%15.31K
-35.50%8.94M
-94.16%807.76K
-67.96%509.48K
Operating profit
-95.34%219.35M
-94.92%170.66M
-94.24%97.78M
199.20%5.08B
286.03%4.71B
378.72%3.36B
306.90%1.7B
201.95%1.7B
183.96%1.22B
188.15%701.81M
Add:Non operating Income
157.28%447.09K
35.78%220.71K
2,196.92%52.98K
992.59%168.87K
--173.78K
--162.55K
114.69%2.31K
-88.20%15.46K
--0
----
Less:Non operating expense
134.63%5.6M
113.31%4.21M
1,036,291.40%1.93M
10.15%3.6M
-26.68%2.39M
608.31%1.97M
-96.34%186.56
-42.67%3.27M
-42.85%3.26M
-95.11%278.66K
Total profit
-95.45%214.19M
-95.04%166.67M
-94.35%95.9M
199.57%5.08B
286.88%4.7B
378.65%3.36B
306.92%1.7B
204.39%1.69B
187.01%1.22B
194.93%701.53M
Less:Income tax cost
-95.60%31.53M
-95.28%24.67M
-94.60%14.44M
180.76%695.93M
296.31%716.58M
388.79%522.71M
297.77%267.32M
205.73%247.87M
186.59%180.81M
192.97%106.94M
Net profit
-95.42%182.66M
-94.99%142M
-94.30%81.46M
202.79%4.38B
285.24%3.99B
376.82%2.84B
308.68%1.43B
204.16%1.45B
187.08%1.03B
195.29%594.59M
Net profit from continuing operation
-95.42%182.66M
-94.99%142M
-94.30%81.46M
202.79%4.38B
285.24%3.99B
376.82%2.84B
308.68%1.43B
204.16%1.45B
187.08%1.03B
195.29%594.59M
Net income from discontinuing operating
----
----
----
--0
----
----
----
--0
----
----
Less:Minority Profit
-74.74%37.36M
-60.64%29.43M
-85.15%6.01M
414.11%172.04M
404.35%147.92M
397.36%74.76M
373.96%40.44M
399.44%33.46M
595.13%29.33M
1,160.40%15.03M
Net profit of parent company owners
-96.21%145.3M
-95.92%112.57M
-94.57%75.45M
197.79%4.21B
281.76%3.84B
376.29%2.76B
307.05%1.39B
201.37%1.41B
182.24%1.01B
189.53%579.56M
Earning per share
Basic earning per share
-96.26%0.63
-95.94%0.49
-94.60%0.49
176.38%27.5
134.73%16.83
191.55%12.07
156.21%9.07
99.40%9.95
87.70%7.17
92.56%4.14
Diluted earning per share
-96.20%0.63
-95.97%0.48
-94.67%0.48
173.90%27.28
133.85%16.58
195.78%11.92
154.52%9.01
99.60%9.96
85.60%7.09
87.44%4.03
Other composite income
3.72M
0
0
Other composite income of parent company owners
----
--3.72M
----
--0
----
----
----
--0
----
----
Other composite income of minority owners
----
----
----
--0
----
----
----
--0
----
----
Total composite income
-95.42%182.66M
-94.86%145.72M
-94.30%81.46M
202.79%4.38B
285.24%3.99B
376.82%2.84B
308.68%1.43B
204.16%1.45B
187.08%1.03B
195.29%594.59M
Total composite income of parent company owners
-96.21%145.3M
-95.79%116.29M
-94.57%75.45M
197.79%4.21B
281.76%3.84B
376.29%2.76B
307.05%1.39B
201.37%1.41B
182.24%1.01B
189.53%579.56M
Total composite income of minority owners
-74.74%37.36M
-60.64%29.43M
-85.15%6.01M
414.11%172.04M
404.35%147.92M
397.36%74.76M
373.96%40.44M
399.44%33.46M
595.13%29.33M
1,160.40%15.03M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
(Q9)2023/09/30(Q6)2023/06/30(Q3)2023/03/31(FY)2022/12/31(Q9)2022/09/30(Q6)2022/06/30(Q3)2022/03/31(FY)2021/12/31(Q9)2021/09/30(Q6)2021/06/30
Total operating revenue -91.62%625.93M-89.77%537.56M-85.03%372.4M272.12%10.53B285.38%7.47B360.27%5.25B267.41%2.49B195.05%2.83B202.78%1.94B216.55%1.14B
Operating revenue -91.62%625.93M-89.77%537.56M-85.03%372.4M272.12%10.53B285.38%7.47B360.27%5.25B267.41%2.49B195.05%2.83B202.78%1.94B216.55%1.14B
Other operating revenue ------0------0------0------0------0
Total operating cost -79.34%561.15M-75.47%453.35M-59.61%305.5M301.42%4.5B285.64%2.72B329.94%1.85B223.85%756.38M176.17%1.12B217.81%704.16M274.25%429.77M
Operating cost -85.91%323.72M-82.69%279.97M-67.92%208.22M393.78%3.49B395.32%2.3B499.38%1.62B310.85%649.07M238.30%707.03M290.56%463.93M360.40%269.81M
Operating tax surcharges -93.71%2.64M-92.69%2.29M-84.88%1.8M366.92%59.79M360.30%41.98M451.13%31.36M261.13%11.87M131.69%12.8M192.50%9.12M215.06%5.69M
Operating expense -38.92%115.48M-34.73%82.1M-7.09%45.96M128.05%450.77M64.88%189.05M62.31%125.78M32.42%49.47M114.06%197.66M126.29%114.67M185.48%77.49M
Administration expense 26.87%78.33M37.23%52.31M47.18%28.13M86.95%141.98M42.22%61.74M29.79%38.12M36.85%19.11M141.35%75.95M183.08%43.41M216.17%29.37M
Financial expense -115.39%-65.66M-63.32%-35.26M-505.52%-11.79M-494.15%-34.94M-435.73%-30.48M-1,082.02%-21.59M-29.28%-1.95M-125.24%-5.88M-327.74%-5.69M-33.64%-1.83M
-Interest expense (Financial expense) -38.55%1.18M84.58%2.46M----61.85%3.42M20.70%1.91M-8.64%1.33M-38.17%477.77K223.16%2.11M6.69%1.59M123.20%1.46M
-Interest Income (Financial expense) -508.99%-71.2M-351.55%-36.36M-----51.70%-17.73M-44.07%-11.69M-48.34%-8.05M-66.26%-3.79M-139.87%-11.69M-139.44%-8.12M-198.30%-5.43M
Research and development -31.34%106.63M26.41%71.93M15.22%33.18M192.56%388.36M97.29%155.31M15.58%56.91M28.16%28.8M89.82%132.74M125.01%78.72M154.33%49.23M
Credit Impairment Loss 199.34%71.82M173.43%43.87M107.08%2.72M-1,635.03%-370.09M-307.06%-72.3M-476.05%-59.74M-699.11%-38.48M-228.15%-21.33M-204.74%-17.76M-195.55%-10.37M
Asset Impairment Loss --36.33M-----------646.67M--------------0--------
Other net revenue 413.32%154.57M288.91%86.45M190.69%30.88M-8,039.46%-953.31M-222.06%-49.33M-368.99%-45.76M-28.98%-34.04M-232.64%-11.71M-244.03%-15.32M-350.23%-9.76M
Fair value change income --------------2.76M--------------0--------
Invest income 87.02%29.67M292.16%29.28M402.51%22.23M5,116.17%35.12M869.73%15.86M7,148.59%7.47M1,902.43%4.42M-48.61%673.29K-37.91%1.64M142.62%102.99K
Net open hedge income --------------0--------------0--------
-Including: Investment income associates ---2.36M-637.28%-2.36M----11.17%-5.13M----89.14%-320.55K----11.10%-5.78M16.39%-2.95M16.39%-2.95M
Exchange income --------------0--------------0--------
Asset deal income ---413.2K---269.11K------9.73K--------------0--------
Other revenue 141.64%17.16M108.53%13.57M38,569.24%5.92M185.75%25.56M779.25%7.1M1,177.73%6.51M106.51%15.31K-35.50%8.94M-94.16%807.76K-67.96%509.48K
Operating profit -95.34%219.35M-94.92%170.66M-94.24%97.78M199.20%5.08B286.03%4.71B378.72%3.36B306.90%1.7B201.95%1.7B183.96%1.22B188.15%701.81M
Add:Non operating Income 157.28%447.09K35.78%220.71K2,196.92%52.98K992.59%168.87K--173.78K--162.55K114.69%2.31K-88.20%15.46K--0----
Less:Non operating expense 134.63%5.6M113.31%4.21M1,036,291.40%1.93M10.15%3.6M-26.68%2.39M608.31%1.97M-96.34%186.56-42.67%3.27M-42.85%3.26M-95.11%278.66K
Total profit -95.45%214.19M-95.04%166.67M-94.35%95.9M199.57%5.08B286.88%4.7B378.65%3.36B306.92%1.7B204.39%1.69B187.01%1.22B194.93%701.53M
Less:Income tax cost -95.60%31.53M-95.28%24.67M-94.60%14.44M180.76%695.93M296.31%716.58M388.79%522.71M297.77%267.32M205.73%247.87M186.59%180.81M192.97%106.94M
Net profit -95.42%182.66M-94.99%142M-94.30%81.46M202.79%4.38B285.24%3.99B376.82%2.84B308.68%1.43B204.16%1.45B187.08%1.03B195.29%594.59M
Net profit from continuing operation -95.42%182.66M-94.99%142M-94.30%81.46M202.79%4.38B285.24%3.99B376.82%2.84B308.68%1.43B204.16%1.45B187.08%1.03B195.29%594.59M
Net income from discontinuing operating --------------0--------------0--------
Less:Minority Profit -74.74%37.36M-60.64%29.43M-85.15%6.01M414.11%172.04M404.35%147.92M397.36%74.76M373.96%40.44M399.44%33.46M595.13%29.33M1,160.40%15.03M
Net profit of parent company owners -96.21%145.3M-95.92%112.57M-94.57%75.45M197.79%4.21B281.76%3.84B376.29%2.76B307.05%1.39B201.37%1.41B182.24%1.01B189.53%579.56M
Earning per share
Basic earning per share -96.26%0.63-95.94%0.49-94.60%0.49176.38%27.5134.73%16.83191.55%12.07156.21%9.0799.40%9.9587.70%7.1792.56%4.14
Diluted earning per share -96.20%0.63-95.97%0.48-94.67%0.48173.90%27.28133.85%16.58195.78%11.92154.52%9.0199.60%9.9685.60%7.0987.44%4.03
Other composite income 3.72M00
Other composite income of parent company owners ------3.72M------0--------------0--------
Other composite income of minority owners --------------0--------------0--------
Total composite income -95.42%182.66M-94.86%145.72M-94.30%81.46M202.79%4.38B285.24%3.99B376.82%2.84B308.68%1.43B204.16%1.45B187.08%1.03B195.29%594.59M
Total composite income of parent company owners -96.21%145.3M-95.79%116.29M-94.57%75.45M197.79%4.21B281.76%3.84B376.29%2.76B307.05%1.39B201.37%1.41B182.24%1.01B189.53%579.56M
Total composite income of minority owners -74.74%37.36M-60.64%29.43M-85.15%6.01M414.11%172.04M404.35%147.92M397.36%74.76M373.96%40.44M399.44%33.46M595.13%29.33M1,160.40%15.03M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg